Newsroom

AI technologies have captured the public imagination and burst into the cultural zeitgeist. Whether through interactive chat programs or AI-generated images, videos, and songs, most of us have witnessed AI’s growth in performing tasks traditionally credited to humans.

The medical device industry is undergoing a seismic transformation. From orthopedic implants and diagnostic platforms to surgical instruments and digital health solutions, innovation is surging, but so is complexity.

In an effort to optimize operations and maximize efficiency, many biotechnology and pharmaceutical companies are looking to integrate AI into their R&D workflows.

Rising R&D costs, extended development timelines, and increasingly complex regulatory environments have created immense pressure on biopharma organisations to innovate faster while delivering more value to patients and stakeholders.

As life sciences organizations increasingly adopt integrated data, AI, and advanced analytics, CRM platforms are becoming powerful tools to anticipate customer needs, personalize engagements, and measure impact in real-time across multiple channels.

Princeton, NJ – October 22, 2025 – Conexus Solutions, Inc., a leading provider of outsourced commercial and technology services for the life sciences industry, has announced the appointment of Chris Wade as Director, Strategic Partnerships – Europe.

The split between major customer relationship management providers Salesforce and Veeva is years away, but the pressure on pharma and biotech companies to consider which path they’ll take is nigh.

In this Q&A, Akshay Kapadia CEO of Conexus Solutions talks about the Veeva and Salesforce split and how the Veeva platform meets the specific CRM requirements of the healthcare sector.

Pharma and biotech are fielding AI pilots across discovery, clinical and commercial, but the gains still hinge on having the right plumbing, culture and talent.